Gene therapy for Parkinson's disease

Thursday, October 22, 2009

The experience of operation carried out on five patients with Parkinson's disease, which depends on the goal of gene therapy in transplantation gene, known as "El - PIN" in the brain to produce dopamine, which causes a decrease in disorder in the brain causing the neurons of Parkinson's disease.

This gene is a virus prompt the brain is capable of continuous production of dopamine missing during illness and causing disorder in the movements and after 44 months was noted improvement in symptoms of the disease, thus encouraging the continuation of treatment by the patient of paralysis, which represents the second disease after Alzheimer's widespread turmoil in the world as a result of nerve cells in the brain.